Graeser, M., Feuerhake, F. und Harbeck, N. (2023) Impact of RNA signatures on p CR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT HER2+/HR− trial [cd]. Freiburg: Universität. doi:10.1158/1078-0432.ccr-22-1587.
Chicago Manual of Style 17th edition (full note)Graeser, Monika, Friedrich Feuerhake, und Nadia Harbeck. Impact of RNA signatures on p CR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT HER2+/HR− trial. Cd. Freiburg: Universität, [2023?], Freiburg: Universität, [2023?]. https://doi.org/10.1158/1078-0432.ccr-22-1587.
American Psychological Association 7th editionGraeser, M., Feuerhake, F., & Harbeck, N. (ca. 2023). Impact of RNA signatures on p CR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT HER2+/HR− trial [Cd]. Universität. https://doi.org/10.1158/1078-0432.ccr-22-1587
Modern Language Association 9th editionGraeser, M., F. Feuerhake, und N. Harbeck. Impact of RNA signatures on p CR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT HER2+/HR− trial. cd, Universität, 2023, https://doi.org/10.1158/1078-0432.ccr-22-1587.
ISO-690 (author-date, Deutsch)GRAESER, Monika, Friedrich FEUERHAKE und Nadia HARBECK, 2023. Impact of RNA signatures on p CR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT HER2+/HR− trial. Freiburg: Universität